Banan R, Abbetmeier-Basse M, Hong B, Dumitru CA, Sahm F, Nakamura M, Krauss JK, Hartmann C (2021) The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas. Neuropathol Appl Neurobiol 47:724–735. https://doi.org/10.1111/nan.12700

Article  PubMed  Google Scholar 

Cree IA, Tan PH, Travis WD, Wesseling P, Yagi Y, White VA, Lokuhetty D, Scolyer RA (2021) Counting mitoses: SI(ze) matters! Mod Pathol 34:1651–1657. https://doi.org/10.1038/s41379-021-00825-7

Article  PubMed  PubMed Central  Google Scholar 

Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, Aizer AA, Alexander BM, Ligon KL, Reardon DA, Wen PY, Al-Mefty O, Ligon AH, Dubuc AM, Beroukhim R, Claus EB, Dunn IF, Santagata S, Bi WL (2022) A molecularly integrated grade for meningioma. Neuro Oncol 24:796–808. https://doi.org/10.1093/neuonc/noab213

Article  CAS  PubMed  Google Scholar 

Komori T (2024) Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next. Brain Tumor Pathol 41:1–3. https://doi.org/10.1007/s10014-023-00474-5

Article  PubMed  Google Scholar 

Le MK, Kawai M, Masui K, Komori T, Kawamata T, Muragaki Y, Inoue T, Tahara I, Kasai K, Kondo T (2024) Glioma image-level and slide-level gene predictor (GLISP) for molecular diagnosis and predicting genetic events of adult diffuse glioma. Bioengineering (Basel). https://doi.org/10.3390/bioengineering12010012

Article  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maas SLN, Hielscher T, Sievers P, Hovestadt V, Suwala AK, Acker T, Weller M, Preusser M, Herold-Mende C, Wick W, von Deimling A, Berghaus N, Sahm F (2024) Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma. Acta Neuropathol 148:17. https://doi.org/10.1007/s00401-024-02777-z

Article  PubMed  PubMed Central  Google Scholar 

Masui K, Mischel PS (2023) Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: toward the establishment of “metabolism-based pathology.” Pathol Int. https://doi.org/10.1111/pin.13379

Article  PubMed  Google Scholar 

Masui K, Onizuka H, Muragaki Y, Kawamata T, Nagashima Y, Kurata A, Komori T (2024) Integrated assessment of malignancy in IDH-mutant astrocytoma with p16 and methylthioadenosine phosphorylase immunohistochemistry. Neuropathology. https://doi.org/10.1111/neup.13005

Article  PubMed  Google Scholar 

Sahm F, Aldape KD, Brastianos PK, Brat DJ, Dahiya S, von Deimling A, Giannini C, Gilbert MR, Louis DN, Raleigh DR, Reifenberger G, Santagata S, Sarkar C, Zadeh G, Wesseling P, Perry A (2024) cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro Oncol. https://doi.org/10.1093/neuonc/noae170

Article  PubMed  PubMed Central  Google Scholar